Dr. Narendra BS Lead Consultant Endocrinology & Diabetology, Aster Whitefield. In recent years, GLP-1 receptor agonists have changed the way people discuss weight loss and diabetes treatment. The medications which doctors developed to treat Type 2 diabetes now serve as common treatments for both obesity and metabolic disorders.
